The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease.
Identifieur interne : 002713 ( Main/Exploration ); précédent : 002712; suivant : 002714The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease.
Auteurs : Ingo J. Diel [Allemagne] ; Jean-Jacques Body [Belgique] ; Alison T. Stopeck [États-Unis] ; Saroj Vadhan-Raj [États-Unis] ; Andrew Spencer [Australie] ; Günther Steger [Autriche] ; Roger Von Moos [Suisse] ; François Goldwasser [France] ; Amy Feng [États-Unis] ; Ada Braun [États-Unis]Source :
- European journal of cancer (Oxford, England : 1990) [ 1879-0852 ] ; 2015.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Anticorps monoclonaux humanisés (usage thérapeutique), Diphosphonates (usage thérapeutique), Dénosumab, Femelle, Humains, Hypercalcémie (), Imidazoles (usage thérapeutique), Modèles de hasards proportionnels, Myélome multiple (anatomopathologie), Myélome multiple (sang), Mâle, Méthode en double aveugle, Tumeurs (anatomopathologie), Tumeurs (sang), Tumeurs du sein (anatomopathologie), Tumeurs du sein (sang), Tumeurs osseuses (sang), Tumeurs osseuses (secondaire).
- MESH :
- anatomopathologie : Myélome multiple, Tumeurs, Tumeurs du sein.
- sang : Myélome multiple, Tumeurs, Tumeurs du sein, Tumeurs osseuses.
- secondaire : Tumeurs osseuses.
- usage thérapeutique : Anticorps monoclonaux humanisés, Diphosphonates, Imidazoles.
- Adulte d'âge moyen, Dénosumab, Femelle, Humains, Hypercalcémie, Modèles de hasards proportionnels, Mâle, Méthode en double aveugle.
English descriptors
- KwdEn :
- Antibodies, Monoclonal, Humanized (therapeutic use), Bone Neoplasms (blood), Bone Neoplasms (secondary), Breast Neoplasms (blood), Breast Neoplasms (pathology), Denosumab, Diphosphonates (therapeutic use), Double-Blind Method, Female, Humans, Hypercalcemia (prevention & control), Imidazoles (therapeutic use), Male, Middle Aged, Multiple Myeloma (blood), Multiple Myeloma (pathology), Neoplasms (blood), Neoplasms (pathology), Proportional Hazards Models.
- MESH :
- chemical , therapeutic use : Antibodies, Monoclonal, Humanized, Diphosphonates, Imidazoles.
- blood : Bone Neoplasms, Breast Neoplasms, Multiple Myeloma, Neoplasms.
- pathology : Breast Neoplasms, Multiple Myeloma, Neoplasms.
- prevention & control : Hypercalcemia.
- secondary : Bone Neoplasms.
- chemical : Denosumab, Double-Blind Method, Female, Humans, Male, Middle Aged, Proportional Hazards Models.
Abstract
We compared the activity of denosumab with zoledronic acid for delaying or preventing hypercalcaemia of malignancy (HCM) in patients with advanced cancer and bone metastases or with multiple myeloma.
DOI: 10.1016/j.ejca.2015.04.017
PubMed: 25976743
Affiliations:
- Allemagne, Australie, Autriche, Belgique, France, Suisse, États-Unis
- Bade-Wurtemberg, Californie, District de Karlsruhe, Région de Bruxelles-Capitale, Texas, Vienne (Autriche), État de New York, Île-de-France
- Bruxelles, Mannheim, Paris, Vienne (Autriche)
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002B67
- to stream PubMed, to step Curation: 002A95
- to stream PubMed, to step Checkpoint: 002A95
- to stream Ncbi, to step Merge: 002568
- to stream Ncbi, to step Curation: 002568
- to stream Ncbi, to step Checkpoint: 002568
- to stream Main, to step Merge: 002713
- to stream Main, to step Curation: 002713
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease.</title>
<author><name sortKey="Diel, Ingo J" sort="Diel, Ingo J" uniqKey="Diel I" first="Ingo J" last="Diel">Ingo J. Diel</name>
<affiliation wicri:level="3"><nlm:affiliation>Center for Gynecological Oncology, Mannheim, Germany. Electronic address: diel@spgo-mannheim.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Center for Gynecological Oncology, Mannheim</wicri:regionArea>
<placeName><region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Karlsruhe</region>
<settlement type="city">Mannheim</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Body, Jean Jacques" sort="Body, Jean Jacques" uniqKey="Body J" first="Jean-Jacques" last="Body">Jean-Jacques Body</name>
<affiliation wicri:level="3"><nlm:affiliation>Centre Hospitalier Universitaire Brugmann, Université Libre de Bruxelles, Brussels, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Centre Hospitalier Universitaire Brugmann, Université Libre de Bruxelles, Brussels</wicri:regionArea>
<placeName><settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Stopeck, Alison T" sort="Stopeck, Alison T" uniqKey="Stopeck A" first="Alison T" last="Stopeck">Alison T. Stopeck</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Internal Medicine, Stony Brook Cancer Center, NY, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Internal Medicine, Stony Brook Cancer Center, NY</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vadhan Raj, Saroj" sort="Vadhan Raj, Saroj" uniqKey="Vadhan Raj S" first="Saroj" last="Vadhan-Raj">Saroj Vadhan-Raj</name>
<affiliation wicri:level="2"><nlm:affiliation>MD Anderson Cancer Center, Houston, TX, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>MD Anderson Cancer Center, Houston, TX</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Spencer, Andrew" sort="Spencer, Andrew" uniqKey="Spencer A" first="Andrew" last="Spencer">Andrew Spencer</name>
<affiliation wicri:level="1"><nlm:affiliation>The Alfred Hospital, Prahran, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The Alfred Hospital, Prahran, Victoria</wicri:regionArea>
<wicri:noRegion>Victoria</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Steger, Gunther" sort="Steger, Gunther" uniqKey="Steger G" first="Günther" last="Steger">Günther Steger</name>
<affiliation wicri:level="3"><nlm:affiliation>Medical University of Vienna, Vienna, Austria.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Medical University of Vienna, Vienna</wicri:regionArea>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Von Moos, Roger" sort="Von Moos, Roger" uniqKey="Von Moos R" first="Roger" last="Von Moos">Roger Von Moos</name>
<affiliation wicri:level="1"><nlm:affiliation>Kantonsspital Graubünden, Chur, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Kantonsspital Graubünden, Chur</wicri:regionArea>
<wicri:noRegion>Chur</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Goldwasser, Francois" sort="Goldwasser, Francois" uniqKey="Goldwasser F" first="François" last="Goldwasser">François Goldwasser</name>
<affiliation wicri:level="3"><nlm:affiliation>Teaching Hospital Cochin, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Teaching Hospital Cochin, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Feng, Amy" sort="Feng, Amy" uniqKey="Feng A" first="Amy" last="Feng">Amy Feng</name>
<affiliation wicri:level="2"><nlm:affiliation>Amgen Inc., Thousand Oaks, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Amgen Inc., Thousand Oaks, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Braun, Ada" sort="Braun, Ada" uniqKey="Braun A" first="Ada" last="Braun">Ada Braun</name>
<affiliation wicri:level="2"><nlm:affiliation>Amgen Inc., Thousand Oaks, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Amgen Inc., Thousand Oaks, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25976743</idno>
<idno type="pmid">25976743</idno>
<idno type="doi">10.1016/j.ejca.2015.04.017</idno>
<idno type="wicri:Area/PubMed/Corpus">002B67</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002B67</idno>
<idno type="wicri:Area/PubMed/Curation">002A95</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002A95</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002A95</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002A95</idno>
<idno type="wicri:Area/Ncbi/Merge">002568</idno>
<idno type="wicri:Area/Ncbi/Curation">002568</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002568</idno>
<idno type="wicri:Area/Main/Merge">002713</idno>
<idno type="wicri:Area/Main/Curation">002713</idno>
<idno type="wicri:Area/Main/Exploration">002713</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease.</title>
<author><name sortKey="Diel, Ingo J" sort="Diel, Ingo J" uniqKey="Diel I" first="Ingo J" last="Diel">Ingo J. Diel</name>
<affiliation wicri:level="3"><nlm:affiliation>Center for Gynecological Oncology, Mannheim, Germany. Electronic address: diel@spgo-mannheim.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Center for Gynecological Oncology, Mannheim</wicri:regionArea>
<placeName><region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Karlsruhe</region>
<settlement type="city">Mannheim</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Body, Jean Jacques" sort="Body, Jean Jacques" uniqKey="Body J" first="Jean-Jacques" last="Body">Jean-Jacques Body</name>
<affiliation wicri:level="3"><nlm:affiliation>Centre Hospitalier Universitaire Brugmann, Université Libre de Bruxelles, Brussels, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Centre Hospitalier Universitaire Brugmann, Université Libre de Bruxelles, Brussels</wicri:regionArea>
<placeName><settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Stopeck, Alison T" sort="Stopeck, Alison T" uniqKey="Stopeck A" first="Alison T" last="Stopeck">Alison T. Stopeck</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Internal Medicine, Stony Brook Cancer Center, NY, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Internal Medicine, Stony Brook Cancer Center, NY</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vadhan Raj, Saroj" sort="Vadhan Raj, Saroj" uniqKey="Vadhan Raj S" first="Saroj" last="Vadhan-Raj">Saroj Vadhan-Raj</name>
<affiliation wicri:level="2"><nlm:affiliation>MD Anderson Cancer Center, Houston, TX, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>MD Anderson Cancer Center, Houston, TX</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Spencer, Andrew" sort="Spencer, Andrew" uniqKey="Spencer A" first="Andrew" last="Spencer">Andrew Spencer</name>
<affiliation wicri:level="1"><nlm:affiliation>The Alfred Hospital, Prahran, Victoria, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The Alfred Hospital, Prahran, Victoria</wicri:regionArea>
<wicri:noRegion>Victoria</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Steger, Gunther" sort="Steger, Gunther" uniqKey="Steger G" first="Günther" last="Steger">Günther Steger</name>
<affiliation wicri:level="3"><nlm:affiliation>Medical University of Vienna, Vienna, Austria.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Medical University of Vienna, Vienna</wicri:regionArea>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Von Moos, Roger" sort="Von Moos, Roger" uniqKey="Von Moos R" first="Roger" last="Von Moos">Roger Von Moos</name>
<affiliation wicri:level="1"><nlm:affiliation>Kantonsspital Graubünden, Chur, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Kantonsspital Graubünden, Chur</wicri:regionArea>
<wicri:noRegion>Chur</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Goldwasser, Francois" sort="Goldwasser, Francois" uniqKey="Goldwasser F" first="François" last="Goldwasser">François Goldwasser</name>
<affiliation wicri:level="3"><nlm:affiliation>Teaching Hospital Cochin, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Teaching Hospital Cochin, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Feng, Amy" sort="Feng, Amy" uniqKey="Feng A" first="Amy" last="Feng">Amy Feng</name>
<affiliation wicri:level="2"><nlm:affiliation>Amgen Inc., Thousand Oaks, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Amgen Inc., Thousand Oaks, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Braun, Ada" sort="Braun, Ada" uniqKey="Braun A" first="Ada" last="Braun">Ada Braun</name>
<affiliation wicri:level="2"><nlm:affiliation>Amgen Inc., Thousand Oaks, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Amgen Inc., Thousand Oaks, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">European journal of cancer (Oxford, England : 1990)</title>
<idno type="eISSN">1879-0852</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Monoclonal, Humanized (therapeutic use)</term>
<term>Bone Neoplasms (blood)</term>
<term>Bone Neoplasms (secondary)</term>
<term>Breast Neoplasms (blood)</term>
<term>Breast Neoplasms (pathology)</term>
<term>Denosumab</term>
<term>Diphosphonates (therapeutic use)</term>
<term>Double-Blind Method</term>
<term>Female</term>
<term>Humans</term>
<term>Hypercalcemia (prevention & control)</term>
<term>Imidazoles (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Multiple Myeloma (blood)</term>
<term>Multiple Myeloma (pathology)</term>
<term>Neoplasms (blood)</term>
<term>Neoplasms (pathology)</term>
<term>Proportional Hazards Models</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Anticorps monoclonaux humanisés (usage thérapeutique)</term>
<term>Diphosphonates (usage thérapeutique)</term>
<term>Dénosumab</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hypercalcémie ()</term>
<term>Imidazoles (usage thérapeutique)</term>
<term>Modèles de hasards proportionnels</term>
<term>Myélome multiple (anatomopathologie)</term>
<term>Myélome multiple (sang)</term>
<term>Mâle</term>
<term>Méthode en double aveugle</term>
<term>Tumeurs (anatomopathologie)</term>
<term>Tumeurs (sang)</term>
<term>Tumeurs du sein (anatomopathologie)</term>
<term>Tumeurs du sein (sang)</term>
<term>Tumeurs osseuses (sang)</term>
<term>Tumeurs osseuses (secondaire)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antibodies, Monoclonal, Humanized</term>
<term>Diphosphonates</term>
<term>Imidazoles</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Myélome multiple</term>
<term>Tumeurs</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Bone Neoplasms</term>
<term>Breast Neoplasms</term>
<term>Multiple Myeloma</term>
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term>
<term>Multiple Myeloma</term>
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Hypercalcemia</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Myélome multiple</term>
<term>Tumeurs</term>
<term>Tumeurs du sein</term>
<term>Tumeurs osseuses</term>
</keywords>
<keywords scheme="MESH" qualifier="secondaire" xml:lang="fr"><term>Tumeurs osseuses</term>
</keywords>
<keywords scheme="MESH" qualifier="secondary" xml:lang="en"><term>Bone Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anticorps monoclonaux humanisés</term>
<term>Diphosphonates</term>
<term>Imidazoles</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Denosumab</term>
<term>Double-Blind Method</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Proportional Hazards Models</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Dénosumab</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hypercalcémie</term>
<term>Modèles de hasards proportionnels</term>
<term>Mâle</term>
<term>Méthode en double aveugle</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We compared the activity of denosumab with zoledronic acid for delaying or preventing hypercalcaemia of malignancy (HCM) in patients with advanced cancer and bone metastases or with multiple myeloma.</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
<li>Australie</li>
<li>Autriche</li>
<li>Belgique</li>
<li>France</li>
<li>Suisse</li>
<li>États-Unis</li>
</country>
<region><li>Bade-Wurtemberg</li>
<li>Californie</li>
<li>District de Karlsruhe</li>
<li>Région de Bruxelles-Capitale</li>
<li>Texas</li>
<li>Vienne (Autriche)</li>
<li>État de New York</li>
<li>Île-de-France</li>
</region>
<settlement><li>Bruxelles</li>
<li>Mannheim</li>
<li>Paris</li>
<li>Vienne (Autriche)</li>
</settlement>
</list>
<tree><country name="Allemagne"><region name="Bade-Wurtemberg"><name sortKey="Diel, Ingo J" sort="Diel, Ingo J" uniqKey="Diel I" first="Ingo J" last="Diel">Ingo J. Diel</name>
</region>
</country>
<country name="Belgique"><region name="Région de Bruxelles-Capitale"><name sortKey="Body, Jean Jacques" sort="Body, Jean Jacques" uniqKey="Body J" first="Jean-Jacques" last="Body">Jean-Jacques Body</name>
</region>
</country>
<country name="États-Unis"><region name="État de New York"><name sortKey="Stopeck, Alison T" sort="Stopeck, Alison T" uniqKey="Stopeck A" first="Alison T" last="Stopeck">Alison T. Stopeck</name>
</region>
<name sortKey="Braun, Ada" sort="Braun, Ada" uniqKey="Braun A" first="Ada" last="Braun">Ada Braun</name>
<name sortKey="Feng, Amy" sort="Feng, Amy" uniqKey="Feng A" first="Amy" last="Feng">Amy Feng</name>
<name sortKey="Vadhan Raj, Saroj" sort="Vadhan Raj, Saroj" uniqKey="Vadhan Raj S" first="Saroj" last="Vadhan-Raj">Saroj Vadhan-Raj</name>
</country>
<country name="Australie"><noRegion><name sortKey="Spencer, Andrew" sort="Spencer, Andrew" uniqKey="Spencer A" first="Andrew" last="Spencer">Andrew Spencer</name>
</noRegion>
</country>
<country name="Autriche"><region name="Vienne (Autriche)"><name sortKey="Steger, Gunther" sort="Steger, Gunther" uniqKey="Steger G" first="Günther" last="Steger">Günther Steger</name>
</region>
</country>
<country name="Suisse"><noRegion><name sortKey="Von Moos, Roger" sort="Von Moos, Roger" uniqKey="Von Moos R" first="Roger" last="Von Moos">Roger Von Moos</name>
</noRegion>
</country>
<country name="France"><region name="Île-de-France"><name sortKey="Goldwasser, Francois" sort="Goldwasser, Francois" uniqKey="Goldwasser F" first="François" last="Goldwasser">François Goldwasser</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002713 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002713 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:25976743 |texte= The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25976743" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
This area was generated with Dilib version V0.6.33. |